Skip to main navigation Skip to search Skip to main content

Researchers from Korea Institute of Oriental Medicine Describe Findings in Parkinson's Disease [Rebamipide (Mucosta®), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson's disease model]

Press/Media

Period2 Jun 2025

Media coverage

1

Media coverage

  • TitleResearchers from Korea Institute of Oriental Medicine Describe Findings in Parkinson's Disease [Rebamipide (Mucosta®), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson's disease model]
    Media name/outletNewsRx Drug Daily
    Country/TerritoryUnited States
    Date2/06/25
    PersonsSeunghoon Lee